Publications

  1. Niaz T, Stephens EH, Gleich SJ, Dearani JA, Johnson JN, Sas DJ, Bly S, Driscoll DJ, Cetta F. Acute Kidney Injury and Renal Replacement Therapy After Fontan Operation. Am J Cardiol. 2021 Dec 15; 161:84-94
    View PubMed
  2. Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol. 2021 Dec 14 [Epub ahead of print]
    View PubMed
  3. Sas DJ, Magen D, Hayes W, Shasha-Lavsky H, Michael M, Schulte I, Sellier-Leclerc AL, Lu J, Seddighzadeh A, Habtemariam B, McGregor TL, Fujita KP, Frishberg Y, ILLUMINATE-B Workgroup. Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children. Genet Med. 2021 Dec 7 Epub 2021 Dec 07
    View PubMed
  4. Cogal AG, Arroyo J, Shah RJ, Reese KJ, Walton BN, Reynolds LM, Kennedy GN, Seide BM, Senum SR, Baum M, Erickson SB, Jagadeesh S, Soliman NA, Goldfarb DS, Beara-Lasic L, Edvardsson VO, Palsson R, Milliner DS, Sas DJ, Lieske JC, Harris PC, Investigators of the Rare Kidney Stone Consortium. Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease. Kidney Int Rep. 2021 Nov; 6 (11):2862-2884 Epub 2021 Sept 08
    View PubMed
  5. Christensen S, Tebben PJ, Sas D, Creo AL. Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature. Horm Res Paediatr. 2021 Oct 19; 313-328 [Epub ahead of print]
    View PubMed
  6. Azer SM, Vaughan LE, Tebben PJ, Sas DJ. 24-Hydroxylase Deficiency Due to CYP24A1 Sequence Variants: Comparison With Other Vitamin D-mediated Hypercalcemia Disorders. J Endocr Soc. 2021 Sep 1; 5 (9):bvab119 Epub 2021 July 02
    View PubMed
  7. Pinto E Vairo F, Prochnow C, Kemppainen JL, Lisi EC, Steyermark JM, Kruisselbrink TM, Pichurin PN, Dhamija R, Hager MM, Albadri S, Cornell LD, Lazaridis KN, Klee EW, Senum SR, El Ters M, Amer H, Baudhuin LM, Moyer AM, Keddis MT, Zand L, Sas DJ, Erickson SB, Fervenza FC, Lieske JC, Harris PC, Hogan MC. Genomics Integration Into Nephrology Practice. Kidney Med. 2021 Sep-Oct; 3(5):785-798. Epub 2021 Jun 29.
    View PubMed
  8. Hanna C, Potretzke TA, Cogal AG, Mkhaimer YG, Tebben PJ, Torres VE, Lieske JC, Harris PC, Sas DJ, Milliner DS, Chebib FT. High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency. Kidney Int Rep. 2021 Jul; 6 (7):1895-1903 Epub 2021 May 12
    View PubMed
  9. Wilbanks J, Hillyer J, Hashim F, Sas D, Hanna C. A toddler with severe hypercalcemia and pyelonephritis: Questions. Pediatr Nephrol. 2021 Apr; 36 (4):857-858 Epub 2020 July 20
    View PubMed
  10. Wilbanks J, Hillyer J, Hashim F, Sas D, Hanna C. A toddler with severe hypercalcemia and pyelonephritis: Answers. Pediatr Nephrol. 2021 Apr; 36 (4):859-861 Epub 2020 July 20
    View PubMed
  11. Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschenes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC, ILLUMINATE-A Collaborators. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med. 2021 Apr 1; 384 (13):1216-1226
    View PubMed
  12. Sas DJ. Editorial Comment. J Urol 2021 Apr; 205 (4):1187 Epub 2021 Jan 22
    View PubMed
  13. Singh P, Viehman JK, Mehta RA, Cogal AG, Hasadsri L, Oglesbee D, Olson JB, Seide BM, Sas DJ, Harris PC, Lieske JC, Milliner DS. Clinical characterization of primary hyperoxaluria type 3 in comparison to types 1 and 2: a retrospective cohort study. Nephrol Dial Transplant. 2021 Feb 5 Epub 2021 Feb 05
    View PubMed
  14. Sas DJ, Enders FT, Gunderson TM, Mehta RA, Olson JB, Seide BM, Banks CJ, Dehmel B, Pellikka PA, Lieske JC, Milliner DS. Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis. Front Med (Lausanne). 2021; 8:592357 Epub 2021 Apr 09
    View PubMed
  15. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Answers. Pediatr Nephrol. 2020 Dec; 36 (12):4085-4087 Epub 2021 Aug 05
    View PubMed
  16. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Questions. Pediatr Nephrol. 2020 Dec; 36 (12):4083-4084 Epub 2021 Aug 05
    View PubMed
  17. Warring SK, Novoa V, Shazly S, Trinidad MC, Sas DJ, Schiltz B, Prieto M, Terzic A, Ruano R. Serial Amnioinfusion as Regenerative Therapy for Pulmonary Hypoplasia in Fetuses With Intrauterine Renal Failure or Severe Renal Anomalies: Systematic Review and Future Perspectives. Mayo Clin Proc Innov Qual Outcomes. 2020 Aug; 4 (4):391-409 Epub 2020 Aug 05
    View PubMed
  18. Sas DJ. Dietary risk factors for urinary stones in children. Curr Opin Pediatr. 2020 Apr; 32 (2):284-287
    View PubMed
  19. Sas DJ, Enders FT, Mehta RA, Tang X, Zhao F, Seide BM, Milliner DS, Lieske JC. Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening. Kidney Int. 2020 Apr; 97 (4):786-792 Epub 2019 Dec 13
    View PubMed
  20. Sas DJ, Harris PC, Milliner DS. Recent advances in the identification and management of inherited hyperoxalurias. Urolithiasis. 2019 Feb; 47 (1):79-89 Epub 2018 Dec 10
    View PubMed
  21. Sas DJ, Becton LJ, Tutman J, Lindsay LA, Wahlquist AH. Clinical, demographic, and laboratory characteristics of children with nephrolithiasis. Urolithiasis. 2016 Jun; 44 (3):241-6 Epub 2015 Oct 14
    View PubMed
  22. Tran CL, Sethi S, Murray D, Cramer CH, Sas DJ, Willrich M, Smith RJ, Fervenza FC. Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease. Pediatr Nephrol. 2016 Apr; 31 (4):683-7 Epub 2016 Jan 13
    View PubMed
  23. Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, Chu DI, Copelovitch L, Saigal CS, Furth SL. Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016 Mar 7; 11 (3):488-96 Epub 2016 Jan 14
    View PubMed
  24. Shatat IF, Taber DJ, Shrivastava S, Weimert NA, Sas DJ, Chavin KD, Orak JK, Baliga PK. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92.
    View PubMed
  25. Shatat IF, Abdallah RT, Sas DJ, Hailpern SM. Serum uric acid in U.S. adolescents: distribution and relationship to demographic characteristics and cardiovascular risk factors. Pediatr Res. 2012 Mar 30.
    View PubMed
  26. Sas DJ. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2062-8. Epub 2011 Jul 07.
    View PubMed
  27. Horner KB, Sas DJ. White urine in an asymptomatic child. J Pediatr. 2011 Aug; 159(2):351. Epub 2011 May 17.
    View PubMed
  28. Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010 Jul; 157(1):132-7. Epub 2010 Apr 1
    View PubMed
  29. Sas D, Hu M, Moe OW, Baum M. Effect of claudins 6 and 9 on paracellular permeability in MDCK II cells. Am J Physiol Regul Integr Comp Physiol. 2008 Nov; 295(5):R1713-9. Epub 2008 Sep 10.
    View PubMed
  30. Gattineni J, Sas D, Dagan A, Dwarakanath V, Baum M. Effect of thyroid hormone on the postnatal renal expression of NHE8. Am J Physiol Renal Physiol. 2008 Jan; 294(1):F198-204. Epub 2007 Oct 31
    View PubMed
  31. Sas D, Enrione MA, Schwartz RH. Pseudomonas aeruginosa septic shock secondary to "gripe water" ingestion. Pediatr Infect Dis J. 2004 Feb; 23(2):176-7.
    View PubMed